Molecular targeting by homocysteine: a mechanism for vascular pathogenesis.

Clin Chem Lab Med

Department of Cell Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

Published: December 2005

Hyperhomocysteinemia is an independent risk factor for cardiovascular disease. Although there is a growing body of evidence that homocysteine plays a causal role in atherogenesis, specific mechanisms to explain the underlying pathology have remained elusive. This review focuses on chemistry unique to the homocysteine molecule to explain its inherent cytotoxicity. Thus, the high pKa of the sulfhydryl group (pKa=10.0) of homocysteine underlies its ability to form stable disulfide bonds with protein cysteine residues, and in the process, alters or impairs the function of the protein. Albumin, fibronectin, transthyretin, annexin II, and factor V have now been identified as molecular targets for homocysteine, and in the case of albumin, the mechanism of targeting has been elucidated.

Download full-text PDF

Source
http://dx.doi.org/10.1515/CCLM.2005.188DOI Listing

Publication Analysis

Top Keywords

homocysteine
5
molecular targeting
4
targeting homocysteine
4
homocysteine mechanism
4
mechanism vascular
4
vascular pathogenesis
4
pathogenesis hyperhomocysteinemia
4
hyperhomocysteinemia independent
4
independent risk
4
risk factor
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!